cancer Downloads
-
Exacta - Model 360 - Advanced Cancer Profiling Technology - Brochure
Exacta™ is an intensive and in-depth multi-analyte tumor profiling. It analyses millions of data points at the molecular and functional levels to reveal threats and vulnerabilities which enable optimal identification of targets for precision treatment selection. ...
-
Celldx - Model 360 - Advanced Tumor Profiling Technology for Personalized Targeted Anti-cancer Treatments - Brochure
CellDx is an intensive and in-depth tumor molecular profiling. It analyses millions of data points at the molecular level to reveal threats and vulnerabilities which enable optimal identification of targets for precision treatment selection. ...
-
Cancer Panels for Cancer Research
CD Genomics is an innovative sequencing and genotyping company. Our cancer panels are designed to address the practical needs of cancer-related studies. ...
By CD Genomics
-
Cancertrack - Model 360 - Cancer Treatments Technology - Brochure
Cancertrack is an advanced non-invasive blood test which provides real time intel on the status of a malignancy from a safe, simple and quick blood draw. Cancertrack profiles molecular features in circulating tumor DNA and circulating tumor RNA and also evaluates ‘Circulating Tumor Cells’ (CTCs). ...
-
Chemoscale - Model 360 - Chemo - Resistance Profiling Technology for Circulating Tumor Associated Cells - Brochure
Chemo-scale is an advanced non-invasive test which provides therapeutically relevant information and is based on a safe, simple, and quick blood draw. Chemo-scale™ investigates in vitro chemo-resistance in Circulating Tumor Associated Cells (CTACs) isolated from the blood sample. CTACs include cancer cells that escape from the tumor and enter the bloodstream (circulating tumor cells, CTCs) ...
-
Why Cancer Panels Stand Out for Cancer Research?
CD Genomics is an innovative sequencing and genotyping company. Our cancer panels are designed to address the practical needs of cancer-related studies. These panels are featured an innovative background cleaning technique that allows plenty of amplicons to be multiplexed in a single reaction pool. ...
By CD Genomics
-
Hunt for miRNA Signatures in Cancer
Sequencing technology has advanced successfully to become one of the most used routine tools for life science research. Not only can it provide a wealth of valuable information, when combined with other research methods, sequencing can also supply massive information. ...
By CD Genomics
-
Targeting Cervical Cancer
Cervical cancer is one of the most common cancers in women. Conventional treatment approaches have limitations such as serious side effects and toxicities. Currently, tumor-targeted delivery of anticancer drugs represents one of the most appropriate options to achieve optimal outcomes from the treatment and improve the quality of ...
-
Why Cancer Panels Stand Out for Cancer Research
CD Genomics is an innovative sequencing and genotyping company. Our cancer panels are designed to address the practical needs of cancer-related studies. These panels are featured an innovative background cleaning technique that allows plenty of amplicons to be multiplexed in a single reaction pool, allowing a large number of cancer-related genes to be detected in a single assay. ...
By CD Genomics
-
Pinaka - Model 360 - Theranostic Profiling Technology for Circulating Tumor Cells - Brochure
Pinaka™ is an advanced non-invasive blood test which provides therapeutically relevant information via a safe, simple and quick blood draw. Pinaka™ evaluates blood sample to detect ‘Circulating Tumor Cells’ (CTCs), which are cancer cells that escape from the tumor and enter the blood stream. Pinaka™ enriches these CTCs from the blood sample and confirms their ...
-
MHC Tetramer for Cancer
MHC tetramers allow for ex vivo selection and proliferation of T-cells specific to tumor-related antigens, which can then be reintroduced to augment the immune system. Cancer immunotherapy would be largely influenced by this ...
-
Cancer Diagnostics Brochure
Identify clinically significant mutations in cancer-associated genes to optimize patient-specific ...
-
Explore Cancer-related Mutations with NGS
Further mutations may occur in the progeny of the cancer cell, leading to the development of tumour cell invasion and metastasis. The application of NGS provides a high-resolution and global view of the cancer genome in a high throughput manner, revealing several novel cancer-related genes and pathways. ...
By CD Genomics
-
CDC recommends HPV vaccination Adobe PDF file Brochure
for now and for the future. Today, there is a strong weapon to prevent several types of cancer in our ...
-
Explore Cancer-related Mutations Using NGS
Cancer is primarily caused by genetic alterations, which may be inherited or acquired in somatic cells. These alterations in oncogenes, tumour suppressor genes or DNA repair genes may enable cells to evade growth inhibition in response to growth-inhibitory signals, leading to the development of a ...
By CD Genomics
-
Dedicated to Creating Better Treatments for Cancer - Datasheet
LIXTE BIOTECHNOLOGY HOLDINGS, INC. is a clinical-stage drug discovery company using biomarker technology to identify enzyme targets associated with cancer to design novel compounds to attack those ...
-
The Reasons for Choosing Our Cancer Panels
CD Genomics's cancer panels are predesigned panels for targeted sequencing of genes and mutations associated with multiple cancer diseases. CD Genomics utilizes targeted NGS sequencing technology to provide more efficient and accurate targeting of specific genes or mutations, and even to detect low-frequency variations in cancer-associated genes. ...
By CD Genomics
-
Twist - Model cfDNA - Comprehensive Cancer Variant- Brochure
NGS-based liquid biopsy is a rapidly evolving application that requires accurate and precise reference standards. The Twist Pan-cancer Reference Standard is a high-quality, standardized control for use in the research and development of NGS-based liquid biopsy assays. This reference standard is ideal for establishing the analytical limit of detection (LoD) for specific cancer variants and as a ...
-
Immunoscore for Colon Cancer Patients - Brochure
To date, the classification of cancers has been based solely on the phenotypic and genotypic characteristics of tumor cells. A new paradigm, scientifically well established and recommended by WHO guidelines, relies on the introduction of the immune response as a new prognostic parameter to predict and refine the clinical outcomes of cancer patients. Maximize patient survival rates with an ...
By Veracyte
-
Hunt for miRNA Signatures in Cancer - A Case Study of Sequencing and Bioinformatics
Sequencing technology has advanced successfully to become one of the most used routine tools for life science research. Not only can it provide a wealth of valuable information, but when combined with other research methods, sequencing can also supply massive information. Sometimes, even with just sequencing and biomarker analysis alone, scientists can also discover biomarkers in cancer. ...
By CD Genomics
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you